|
1
|
Din MAU and Shaikh H: Adenoid cystic
cancer. StatPearls. StatPearls Publishing; Treasure Island, FL:
2025
|
|
2
|
Persson M, Andrén Y, Mark J, Horlings HM,
Persson F and Stenman G: Recurrent fusion of MYB and NFIB
transcription factor genes in carcinomas of the breast and head and
neck. Proc Natl Acad Sci USA. 106:18740–18744. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferrarotto R, Mitani Y, Diao L, Guijarro
I, Wang J, Zweidler-McKay P, Bell D, William WN Jr, Glisson BS,
Wick MJ, et al: Activating NOTCH1 mutations define a distinct
subgroup of patients with adenoid cystic carcinoma who have poor
prognosis, propensity to bone and liver metastasis, and potential
responsiveness to notch1 inhibitors. J Clin Oncol. 35:352–360.
2017. View Article : Google Scholar
|
|
4
|
Coca-Pelaz A, Rodrigo JP, Bradley PJ,
Vander Poorten V, Triantafyllou A, Hunt JL, Strojan P, Rinaldo A,
Haigentz M Jr, Takes RP, et al: Adenoid cystic carcinoma of the
head and neck-an update. Oral Oncol. 51:652–661. 2015. View Article : Google Scholar
|
|
5
|
Onaga R, Enokida T, Ito K, Ueda Y, Okano
S, Fujisawa T, Wada A, Sato M, Tanaka H, Takeshita N, et al:
Combination chemotherapy with taxane and platinum in patients with
salivary gland carcinoma: A retrospective study of docetaxel plus
cisplatin and paclitaxel plus carboplatin. Front Oncol.
13:11851982023. View Article : Google Scholar
|
|
6
|
Tchekmedyian V, Sherman EJ, Dunn L, Tran
C, Baxi S, Katabi N, Antonescu CR, Ostrovnaya I, Haque SS, Pfister
DG and Ho AL: Phase II study of lenvatinib in patients with
progressive, recurrent or metastatic adenoid cystic carcinoma. J
Clin Oncol. 37:1529–1537. 2019. View Article : Google Scholar
|
|
7
|
Gagnier JJ, Kienle G, Altman DG, Moher D,
Sox H and Riley D; CARE Group, : The CARE guidelines:
Consensus-based clinical case reporting guideline development. J
Med Case Rep. 7:2232013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017.PubMed/NCBI
|
|
9
|
U.S. Department of Health and Human
Services, . Common Terminology Criteria for Adverse Events (CTCAE)
Version 5.0. https://www.ctc.ucl.ac.uk/TrialDocuments/Uploaded/Common%20Terminology%20Criteria%20for%20Adverse%20Events%20(CTCAE)%20v5.0_14092023_0.pdfSeptember
13–2025
|
|
10
|
Vinuth D, Agarwal P, Dhirawani RB and Dube
G: Atypical case of primary intraosseous adenoid cystic carcinoma
of mandible. J Oral Maxillofac Pathol. 17:436–439. 2013. View Article : Google Scholar
|
|
11
|
Sasaki E, Yamagata K, Hagiwara T, Takasaki
R, Fukuzawa S, Uchida F, Ishibashi-Kanno N and Bukawa H: A case of
primary intraosseous adenoid cystic carcinoma of the mandible. Case
Rep Dent. 2023:24220862023.
|
|
12
|
Savithri V, Suresh R, Janardhanan M,
Aravind T and Mohan M: Primary intraosseous adenoid cystic
carcinoma with widespread skeletal metastases showing features of
high-grade transformation. Head Neck Pathol. 15:715–722. 2021.
View Article : Google Scholar
|
|
13
|
Nagao T: ‘Dedifferentiation’ and
high-grade transformation in salivary gland carcinomas. Head Neck
Pathol. 7 (Suppl 1):S37–S47. 2013. View Article : Google Scholar
|
|
14
|
Seethala RR, Hunt JL, Baloch ZW, Livolsi
VA and Leon Barnes E: Adenoid cystic carcinoma with high-grade
transformation: A report of 11 cases and a review of the
literature. Am J Surg Pathol. 31:1683–1694. 2007. View Article : Google Scholar
|
|
15
|
MacDonald DS: Maxillofacial fibro-osseous
lesions. Clin Radiol. 70:25–36. 2015. View Article : Google Scholar
|
|
16
|
Vidović Juras D, Škrinjar I, Manojlović S,
Blivajs I, Franćeski D, Manojlović L and Vučićević Boras V: Case of
unrecognised of maxillary adenoid cystic carcinoma. Acta Stomatol
Croat. 53:82–85. 2019. View Article : Google Scholar
|
|
17
|
Wáng YXJ: Advance modern medicine with
clinical case reports. Quant Imaging Med Surg. 4:439–443. 2014.
|
|
18
|
Zupancic M, Näsman A, Friesland S and
Dalianis T: Adenoid cystic carcinoma, clinical presentation,
current treatment and approaches towards novel therapies.
Anticancer Res. 44:1325–1334. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee RH, Wai KC, Chan JW, Ha PK and Kang H:
Approaches to the management of metastatic adenoid cystic
carcinoma. Cancers (Basel). 14:56982022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiu S, Li Y and Liu F: Standardized
treatment of oral cancer under the guidance of clinical practice
guidelines of national comprehensive cancer network. Hua Xi Kou
Qiang Yi Xue Za Zhi. 42:566–571. 2024.(In English, Chinese).
|
|
21
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C,
Bogdahn U, et al: Radiotherapy plus concomitant and adjuvant
temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van Herpen C, Vander Poorten V, Skalova A,
Terhaard C, Maroldi R, van Engen A, Baujat B, Locati LD, Jensen AD,
Smeele L, et al: Salivary gland cancer: ESMO-European reference
network on rare adult solid cancers (EURACAN) clinical practice
guideline for diagnosis, treatment and follow-up. ESMO Open.
7:1006022022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hiraga S, Miyoshi Y and Kishimoto S:
Successful treatment of multiple pulmonary metastases of adenoid
cystic carcinoma of the external auditory meatus with TS-1. Gan To
Kagaku Ryoho. 31:1115–1117. 2004.(In Japanese). PubMed/NCBI
|
|
24
|
Matsumoto M, Nomiyama T, Nakae J and
Nishikawa H: Combination chemotherapy for a senile patient with
adenoid cystic carcinoma of the esophagus: A case report. Jpn J
Clin Oncol. 23:258–262. 1993.
|
